Featured Archives - Page 11 of 22

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

June 7, 2025

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

June 6, 2025

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

THIS WEEK'S STORIES

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

June 3, 2025

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

June 5, 2025

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

June 7, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

Most Read

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

AI-Powered Tool Set to Revolutionize Type 1 Diabetes Diagnosis and Treatment

ZEISS CLARUS 700 Retinal Imaging System Receives Approval in China

Vera Whole Health and Anthem Expand Primary Care Access in Richmond Amid Physician Shortage

EDITOR PICKS

Upendra Mishra’s After the Fall Now Available on Amazon, Marking a Bold New Entry into the Transformational Book Market

MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

THIS WEEK'S STORIES

TriLink and Quantoom Partner to Expand Access to mRNA Vaccines and Therapeutics Globally

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

POPULAR CATEGORY

ABOUT US

FOLLOW US